Philip T. Sager
Technik-/Wissenschafts-/F&E-Leiter bei Thryv Therapeutics, Inc.
Profil
Philip T.
Sager is currently the Director & Chief Medical Officer at Thryv Therapeutics, Inc. He is also a Member of The International Council on Harmonisation of Tech Rqmts.
Previously, he was an Independent Director at Anthera Pharmaceuticals, Inc. from 2014 to 2019.
He was also a Director at Schering-Plough Research Institute from 2001 to 2004 and Vice President-Clinical Research at Gilead Sciences, Inc. from 2009 to 2010.
He has also worked as a Faculty Member at the University of California, Los Angeles.
Dr. Sager received his undergraduate degree from Massachusetts Institute of Technology and his doctorate from Yale School of Medicine.
Aktive Positionen von Philip T. Sager
| Unternehmen | Position | Beginn |
|---|---|---|
| The International Council on Harmonisation of Tech Rqmts | Corporate Officer/Principal | 01.01.2014 |
Thryv Therapeutics, Inc.
 Thryv Therapeutics, Inc. Medical/Nursing ServicesHealth Services LQT Therapeutics, Inc. engages in the development of therapies for the treatment of all forms of Long QT Syndrome. The company was founded by Anthony Rosenzweig, Saumya Das and David Milan and is headquartered in Laval, Canada. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Philip T. Sager
| Unternehmen | Position | Ende |
|---|---|---|
| ANTHERA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.01.2019 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01.01.2010 |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Direktor/Vorstandsmitglied | 01.01.2004 |
| University of California, Los Angeles | Corporate Officer/Principal | - |
Ausbildung von Philip T. Sager
| Massachusetts Institute of Technology | Undergraduate Degree |
| Yale School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| ANTHERA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Health Technology |
| The International Council on Harmonisation of Tech Rqmts | |
Thryv Therapeutics, Inc.
Thryv Therapeutics, Inc. Medical/Nursing ServicesHealth Services LQT Therapeutics, Inc. engages in the development of therapies for the treatment of all forms of Long QT Syndrome. The company was founded by Anthony Rosenzweig, Saumya Das and David Milan and is headquartered in Laval, Canada. | Health Services |
